Summary:
A randomized, double-blind, placebo-controlled study to test the safety and efficacy of a study drug in participants exhibiting mood or behavioral changes associated with Alzheimer's Disease.
Qualified Participants Must:
• Be between 50 and 90 years of age
•
Have a reliable study partner/caregiver who will accompany them to every appointment
•
Be exhibiting mood or behavioral changes associated with Alzheimer's Disease
Qualified Participants May Receive:
Neuroimaging, laborary testing, study medication and medical evaluations at no cost as well as compensation for travel.